RxDoctor Payments Data

Nicole Romeo

Acute Care · New York, NYNPI 1982170650

Payments from drug & device makers

$1,053in general payments, 2019–2025

Across 47 payments — averaging $22.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$372
  • Boehringer Ingelheim$243
  • Johnson & Johnson$182
  • Novartis$67
  • AstraZeneca$59
  • AbbVie$52
  • plus $78 from 3 others

What the payments were for

  • Food & beverage$1,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,053 in reported general payments places this provider in the 80th percentile of 980 acute care providers in New York.

See all acute care providers in New York

Medicare billing

Part B allowed, 2024
$1,520
Medicare patients
23
Services billed
23

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefpodoxime Proxetil15$473
Metoprolol Succinate14$275
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$68

Paid to pharmacies, not to this prescriber.

Other acute care in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →